Breast cancer (BC) is the most common cancer in women in the United States. There has
been an increasing incidence and decreasing mortality rate of BC cases over the past …

The interaction between the microbial communities in the human body and the onset and
progression of cancer has not been investigated until recently. The vast majority of the …

Background Microbial dysbiosis has emerged as an important element in the development
and progression of various cancers, including breast cancer. However, the microbial …

Estrogen circulating in blood has been proved to be a strong biomarker for breast cancer. A
β-glucuronidase enzyme (GUS) from human gastrointestinal tract (GIT) microbiota including …

Microbes are widely present in various organs of the human body and play important roles
in numerous physiological and pathological processes. Nevertheless, owing to multiple …

Background Observational epidemiological studies suggested an association between the
gut microbiota and breast cancer, but it remains unclear whether the gut microbiota causally …

Oncobiosis has emerged as a key contributor to the development, and modulator of the
treatment efficacy of cancer. Hereby, we review the modalities through which the oncobiome …

With the recent description of the molecular and cellular characteristics that enable
acquisition of both core and new hallmarks of cancer, the consequences of transcription …

The microbiota is emerging as a key player in cancer due to its involvement in several host
physiological functions, including digestion, development of the immune system, and …

Breast cancer has a high mortality rate among malignant tumors, with metastases identified
as the main cause of the high mortality. Dysbiosis of the gut microbiota has become a key …